This is a set of images from an MRI of the brain in a patient with TSC.This is an image from a contrast-enhanced CT of the abdomen in another patient with TSC.This computed tomography image shows randomly arranged cysts in both lungs.  The patient had TSC and a renal AML.
Find information on thousands of medical conditions and prescription drugs.

Tuberous Sclerosis

Tuberous sclerosis, (meaning "hard potatoes"), is a rare genetic disorder primarily characterized by a triad of seizures, mental retardation, and skin lesions (called adenoma sebaceum). This "classic" Vogt triad is present in 30-50% of cases; in particular, up to 30% of tuberous sclerosis reportedly have normal mentation. Tuberous sclerosis, along with Neurofibromatosis type I, Neurofibromatosis type II (a.k.a. MISME syndrome), Sturge-Weber, and Von Hippel-Lindau compromise the Phakomatoses or neurocutaneous syndromes, all of which have neurologic and dermatologic lesions. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
Candidiasis
Tachycardia
Taeniasis
Talipes equinovarus
TAR syndrome
Tardive dyskinesia
Tarsal tunnel syndrome
Tay syndrome ichthyosis
Tay-Sachs disease
Telangiectasia
Telangiectasia,...
TEN
Teratoma
Teratophobia
Testotoxicosis
Tetanus
Tetraploidy
Thalassemia
Thalassemia major
Thalassemia minor
Thalassophobia
Thanatophobia
Thoracic outlet syndrome
Thrombocytopenia
Thrombocytosis
Thrombotic...
Thymoma
Thyroid cancer
Tick paralysis
Tick-borne encephalitis
Tietz syndrome
Tinnitus
Todd's paralysis
Topophobia
Torticollis
Touraine-Solente-Golé...
Tourette syndrome
Toxic shock syndrome
Toxocariasis
Toxoplasmosis
Tracheoesophageal fistula
Trachoma
Transient...
Transient Global Amnesia
Transposition of great...
Transverse myelitis
Traumatophobia
Treacher Collins syndrome
Tremor hereditary essential
Trichinellosis
Trichinosis
Trichomoniasis
Trichotillomania
Tricuspid atresia
Trigeminal neuralgia
Trigger thumb
Trimethylaminuria
Triplo X Syndrome
Triploidy
Trisomy
Tropical sprue
Tropophobia
Trypanophobia
Tuberculosis
Tuberous Sclerosis
Tularemia
Tungiasis
Turcot syndrome
Turner's syndrome
Typhoid
Typhus
Tyrosinemia
U
V
W
X
Y
Z
Medicines

This grouping is an artifact of an earlier time in medicine, before the distinct genetic basis of each of these diseases was understood.

The neuropathologic findings of the cortical "tubers" (sclerose tubereuse) was first described by Désiré-Magloire Bourneville in 1880.

Individuals with tuberous sclerosis may experience none or all of the symptoms with varying degrees of severity. Tuberous sclerosis is a multi-system disease that can affect the brain, kidneys, heart, eyes, lungs, and other organs. Small benign tumors may grow on the face and eyes, as well as in the brain, kidneys, and other organs. Neuroimaging studies may be able to confirm the diagnosis. Seizures most often begin in the first year of life.

Tuberous sclerosis' acronym is T.S.C. (Tuberous sclerosis complex) so as to avoid confusion with Tourette's Syndrome.

Genetics

Tuberous sclerosis (TSC) is a genetic disorder caused by mutations on either of two genes TSC1 and TSC2. It has an autosomal dominant pattern of inheritance and penetrance is 100%. The incidence is between 1/6,000 and 1/10,000. One third of cases are inherited; the rest are new mutations.

TSC1 is located on chromosome 9q34 and encodes for the protein hamartin. It was discovered in 1997. TSC2 is located on chromosome 16p13.3 and encodes for the protein tuberin. It was discovered in 1993. TSC2 is contiguous with PKD1 (which causes one form of polycystic kidney disease). Gross deletions affecting both genes may account for the 2% of individuals with TSC who develop PKD in childhood.

TSC1 and TSC2 are both tumor suppressor genes that function according to Knudson's "two hit" hypothesis. That is, a second random mutation must occur before a tumor can develop. This explains the wide expressivity of the disease. Of the two, TSC2 has been associated with a more severe form of TSC. However, the difference is subtle and statistical and cannot be used to identify the mutation clinically. Estimates of the proportion of TSC caused by TSC2 ranges from 55% to 80-90%. Current genetic tests have difficulty locating the mutation in approximately 20% of individuals.

Hamartin/tuberin function as a complex, whose biological activity appears to be a Rheb GTPase. They function within the growth factor (insulin) signalling pathway and are involved in suppressing mTOR signalling.

Read more at Wikipedia.org


[List your site here Free!]


Tuberous sclerosis
From American Family Physician, 2/1/91 by James Provenzale

[TABLES HAVE BEEN OMITTED]

Although tuberous sclerosis is an inherited disorder with an autosomal dominant pattern of transmission, 50 percent of cases are sporadic. The disease is characterized by mental retardation, seizures and adenoma sebaceum; however, mental deficiency is not always present. Approximately 30 percent of patients have normal intelligence. Seizures are always present in patients with mental retardation and in most patients with normal intelligence.1

Cutaneous markers, a characteristic feature of the disease, include adenoma sebaceum (a slightly elevated rash that is most commonly seen in the nasolabial folds and on the cheeks); the shagreen patch (a roughened area of skin usually seen in the midline of the lower back), and hypopigmented spots in the midline of the lower back or anywhere on the trunk and limbs. The hypopigmented areas on the trunk and limbs may not be visible to the unaided eye, but can be seen under ultraviolet light.

Pathophysiology

Tuberous sclerosis derives its name from cortical tubers on the gyral surface of the brain, one of the many forms of hamartomas in this disease. Subependymal nodules, common along the inner margins of the cerebral ventricles, are another form of central nervous system hamartoma. Tuberal calcification commonly occurs, which often allows the disease to be diagnosed on plain radiographs of the skull.2 Malignant degeneration of the tubers occasionally occurs, usually in the form of giant cell astrocytoma.

Hamartomas are benign tumors consisting of an overgrowth of one or more tissues normally found in the area of tumor development. In tuberous sclerosis, hamartomas may develop in the central nervous system, ovaries, adrenal glands, liver and thyroid gland.3 In addition, cardiac rhabdomyomas and sclerotic lesions of bone may be seen. Renal lesions, often multiple and bilateral, are seen in approximately 75 percent of patients.

Patients with renal lesions commonly develop angiomyolipomas (tumors composed of variable amounts of fat, muscle and blood vessels). Because the vascular components of angiomyolipomas lack the normal elastic components, aneurysm formation is relatively common. The sudden onset of flank pain or anemia may herald the onset of renal hemorrhage secondary to intrarenal aneurysmal rupture. Isolated angiomyolipomas may be seen in otherwise normal patients, most commonly in middle-aged women.

Pulmonary abnormalities are also seen in tuberous sclerosis and are marked by progression of smooth muscle in pulmonary septae, bronchi and lymphatics. These abnormalities also occur in lymphangiomyomatosis, a condition in young females that is manifested by recurrent pleural effusions and pneumothoraces.

Radiologic Manifestations

Calcified intracranial hamartomas can be visualized on plain radiographs of the skull Figure 1). However, such radiographic findings are nonspecific, since intracranial calcification may also be seen in a number of infectious processes, including intrauterine toxoplasmosis, intrauterine cytomegalovirus infection and adult toxoplasmosis. In addition, hyperparathyroidism may produce calcification in the basal ganglia. Furthermore, areas of increased density within the skull vault are seen in approximately half of patients with tuberous sclerosis,2 and may be difficult to distinguish on plain radiographs from intracerebral calcification.

Computed tomography (CT) demonstrates the predominantly periventricular location of the calcified hamartomas Figures 2 and 3). The subependymal and subcortical hamartomas may undergo malignant degeneration to giant cell astrocytomas. This change may be manifested by contrast enhancement of one of these lesions. Giant cell astrocytomas occurring at the foramen of Monro can result in hydrocephalus due to ventricular outlet obstruction.1

Plain radiographs of the chest often demonstrate a progressive reticulonodular abnormality. This abnormality cannot be distinguished radiographically from idiopathic pulmonary fibrosis. In pulmonary fibrosis, however, lung volumes are diminished; they are normal or increased in tuberous sclerosis. Recurrent pleural effusions may be seen in tuberous sclerosis and lymphangiomyomatosis.

Renal abnormalities are best evaluated by ultrasound examination or, preferably, CT scanning. Ultrasound may demonstrate a variety of findings, including a renal mass with intrarenal foci of increased echogenicity (bright regions). These areas represent fat or hemorrhage within an angiomyolipoma. However, when the lipomatous component is not pronounced, the renal mass may be difficult to distinguish from other renal neoplasms. CT examination often allows a specific diagnosis Figure 4). The kidney usually appears enlarged and heterogeneous, with low attenuation (dark regions) representing fat interspersed within the kidney. Regions of acute hemorrhage are demonstrated as focal areas of high attenuation (bright areas).

In the appropriate clinical setting, the diagnosis may be made with confidence by CT examination. Angiographic features of renal involvement are multiple intrarenal aneurysms and tortuous vessels. However, these findings are often absent if the angiomatous component of the tumor is not pronounced. In the absence of a known diagnosis of tuberous sclerosis or when the characteristic features are lacking, pathologic examination following nephrectomy is necessary.

REFERENCES

1. Gean A. The phakomatoses. In: Taveras JM, Ferrucci JT, eds. Radiology: diagnosis, imaging, intervention. Vol. 3. Philadelphia: Lippincott, 1988.

2. Medley BE, McLeod RA, Houser OW. Tuberous sclerosis. Semin Roentgenol 1976;11:35-54.

3. Bender BL, Yunis EJ. The pathology of tuberous sclerosis. Pathol Ann 1982;17(Pt 1):33982.

4. Pare JA, Fraser RG. Synopsis of diseases of the chest. Philadelphia: Saunders, 1983:660-2.

COPYRIGHT 1991 American Academy of Family Physicians
COPYRIGHT 2004 Gale Group

Return to Tuberous Sclerosis
Home Contact Resources Exchange Links ebay